Month: February 2020

Isoray Announces Second Quarter Fiscal 2020 Financial Results

Revenue for the second quarter of fiscal 2020 grew 16% to $2.21 million versus $1.90 million in the prior year comparable period.

Isoray Collaborates with MIM Software to Deliver an Advanced Treatment Solution for Recurrent Head and Neck Cancers

Bringing together Isoray’s Cesium Blu brachytherapy seeds in mesh with MIM Software’s powerful brachytherapy treatment planning software provides physicians with all the anatomical information they need to effectively place the Cesium Blu seeds exactly where they are needed to treat the patient’s cancer.

Scroll to top